NSAIDs and prostate cancer risk.
DuBois
Raymond N
RN
Department of Medicine, The Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6838, USA. raymond.dubois@vanderbilt.edu
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001284:Atrophy / Q000201:enzymology; D051546:Cyclooxygenase 2 / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000201:enzymology / Q000473:pathology; D008297:Male; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000201:enzymology* / Q000473:pathology*; D015854:Up-Regulation / Q000502:physiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D051546:Cyclooxygenase 2